Home »
(HealthDay)—If you’re older and your legs ache, it could be nothing—or it could be a sign of peripheral artery disease (PAD). Have you ever even heard of it? Maybe not. That’s why the Society for
There are a multitude of chemical compounds that play a variety of functions in organisms including proteins, lipids, and carbohydrates. Glycans, which until recently have been poorly understood, are another class of compounds that have
It is now possible to screen newborn babies for pyridoxine-dependent epilepsy (PDE), a severe inherited metabolic disorder. This screening promises to enable better and earlier treatment of the disease. To identify new biomarkers that can
Eating red meat may have a bad reputation for being bad for the heart, but new research found that lean beef may have a place in healthy diets, after all. In a randomized controlled study,
People with Crohn’s disease are typically treated with powerful anti-inflammatory medications that act throughout their body, not just in their digestive tract, creating the potential for unintended, and often serious, side effects. New research from
An international team of scientists from Nanyang Technological University, Singapore (NTU Singapore), Brown University and the Massachusetts Institute of Technology (MIT) has developed an artificial intelligence (AI) platform that could one day be used in
In the simplest terms, a healthy lifestyle is a way of living that reduces your risk of becoming seriously ill or reduces your life expectancy. Although we cannot prevent all diseases, many serious illnesses can
An international team of researchers has identified the CNNM4 protein as a key regulator of magnesium in the liver and potential therapeutic target for non-alcoholic fatty liver disease, according to a study published in the
Subtle memory deficits are common in normal aging as well as Alzheimer disease (AD), the leading cause of dementia in older adults. This makes AD difficult to diagnose in its early stages. As there is
Researchers from the Mitochondrial Medicine Frontier Program at Children’s Hospital of Philadelphia (CHOP) have demonstrated how one combination of therapies may be beneficial for patients with mitochondrial respiratory chain disorders. This preclinical research paves the